Fabian Sandoval

, MD

CEO and Research Director, Emerson Clinical Research Institute

Dr. Fabian Sandoval, CEO and Research Director, has over 25 years of bench to bedside research experience. His diversified research career has been in academia, healthcare systems and the public sector. He received his Bachelor of Science in molecular and cellular biology from Marymount University, and his Doctorate of Medicine from the Autonomous University of Guadalajara, School of Medicine.Before opening the doors to Emerson Clinical Research Institute (ECRI), Dr. Sandoval conducted bench research at the National Institutes of Neurological Disorders and Stroke (NINDS), where he focused his work on Early Onset Alzheimer’s Disease, and Cretzfelt-Jakob Disease. At the NIH’s Clinical Center he conducted research in the outpatient Oncology unit, followed by his successful support of an NIH RO1 grant on preventing epilepsy in post-traumatic brain injury patients in adults and children, simultaneously run at the Washington Hospital Center and Children’s National Medical Center.

Read more
For further information

This Speaker's Sessions

Town Hall
Wednesday Oct. 21
2:00 PM
ET
Watch Replay
Now Live!

No Access, No Justice: Addressing Systemic Racism in Alzheimer’s Research and Health Services

The impacts of systemic racism are being discussed more openly than ever before, from policing to COVID-19’s effects on people of color. This town hall will explore the role that systemic racism has played in shaping access to Alzheimer’s research and health services, from exclusionary study protocols to discrimination against researchers of color. Speakers will explore solutions for addressing the effects of racism through equity-centered research, policymaking and infrastructure development. Key question: What goals can we set to help address the effects of systemic racism in access to Alzheimer’s health services and research?

With a special message from Reverend Al Sharpton.

View SessionWatch Replay